Lv32
208 积分 2024-06-30 加入
The next generation of immunotherapies for lung cancers
4天前
已完结
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
5天前
已完结
Lung cancer
5天前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
5天前
已完结
First-Line Immunotherapy for Non–Small-Cell Lung Cancer
5天前
已完结
Why Not Adore ADAURA?—The Trial We Need vs the Trial We Got
11天前
已完结
Adjuvant Treatments for Surgically Resected Non–Small Cell Lung Cancer Harboring EGFR Mutations
11天前
已完结
Model-based Drug Development
21天前
已完结
Decision‐making in early clinical drug development
21天前
已完结
Management of EGFR-Variant and ALK-Positive Non–Small Cell Lung Cancer Brain Metastasis
2个月前
已完结
皖公网安备34019202002308
